Fig. 2From: Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathyThe box-and-whisker plots for the mean BCVA changes after second-line treatments. BCVA, best-corrected visual acuityBack to article page